The objective of this study was to evaluate a new method for the delineation of VM CTVs based on pretargeted anti-CEA iPET, compared with reference MRI images and conventional functional PET/CT imaging, in patients with medullary thyroid carcinoma (MTC) or breast cancer (BC). This evidence concerns the gene CEACAM5 and breast carcinoma.